|
Market Closed -
Nasdaq
16:00:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 46.11 USD | +1.56% |
|
-3.37% | +64.80% |
| 09-04 | After obesity, pharma seeks its next mega-blockbuster in sleep | |
| 08-25 | Alkermes plc Publishes Data From Vibrance-1 Phase 2 Study Of Alixorexton In Adults With Narcolepsy Type 1 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- ALKS Stock
- Charts Alkermes plc
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
















